Proactive Investors Australia | Cellmid Limited receives federal research and development tax refund Proactive Investors UK Recent studies have demonstrated that the company's lead anti-midkine (MK) antibodies slowing primary tumour growth, reducing the spread of cancer and slowing the formation of blood vessels in different tumour types, which is a fundamental step in ... CELLMID LIMITED : R&D Tax refund received |